此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effectiveness of Shared Decision Making(SDM)on Patients With Poor Control Type 2 Diabetes (SDM)

2026年9月4日 更新者:Fooyin University
The study is a pilot study, using a convenient sampling method, targeting at outpatient patients with type 2 diabetes who participate in the diabetes co-care program and poor blood sugar control as the research subjects, and randomly assigned. The number of samples is expected to receive 30 patients in each group. The attrition rate estimates about 20%, so there should be 76 people in total, and 38 people in each group. The experimental group was involved in SDM health education; the control group was involved in routine health education. After the implementation of the measures, the self-efficacy and health promotion behavior changes of the two groups and the effectiveness of disease control (glycated hemoglobin, body mass index, waist circumference) were tracked.

研究概览

地位

完全的

条件

干预/治疗

详细说明

Background Diabetes and hyperglycemia not only increase the risk of complications of cardiovascular disease and lead to a situation involving exposure to danger of death. Meanwhile, the patient's self-management is one of the key factors affecting the quality control of blood sugar. Thereby, Shared Decision Making (SDM) is a patient-centered medical implementation method that healthcare professionals and patients jointly participate in treatment decision-making to reach a consensus, which can stimulate the health care ability of participants to achieve treatment goals.

Purpose: This research aims to implement the SDM model based on self-efficacy theory through individualized decision-making to strengthen the behavioral motivation of diabetic patients and finally, to improve the patient's health promotion behavior and the effectiveness of blood sugar control.

Method: Study Type: Interventional Actual Enrollment:76 participants Allocation:Randomized Intervention Model:Parallel Assignment Masking:Single(Participant)

Expected results:

It is hoped that the implementation of SDM model will be used to strengthen the behavioral motivation of diabetic patients through individualized decision-making, and to confirm whether it can effectively improve the patient's health behavior and the effectiveness of disease control.

研究类型

介入性

注册 (实际的)

70

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Taiwan
      • Tainan、Taiwan、台湾、709204
        • An Nan Hospition-China Medical University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Aged>20y/o
  • Diagnosed by a physician as type 2 diabetes
  • The Diabetes Participated in the Diabetes Shared Care Network
  • Glycosylated hemoglobin (A1C)> 7.5%
  • Can communicate in Chinese or Taiwanese.

Exclusion Criteria:

  • People with mental or cognitive impairment who cannot communicate
  • Health Literacy score lower than 6 points

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
无干预:Control group:as usual care
The control group received as usual care.
实验性的:Experimental group:The intervention of SDM
The experimental group received the intervention of SDM 3 times for 3 months,
The experimental group received the intervention of SDM 3times/month for 3months, then follow the health promotion behavior compliance by phone once a month.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diabetes self-efficacy scale
大体时间:Pre-test (baseline)
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
Pre-test (baseline)
Diabetes self-efficacy scale
大体时间:1 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
1 months after intervnetion
Diabetes self-efficacy scale
大体时间:3 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
3 months after intervnetion
Diabetes health literacy scale
大体时间:Pre-test (baseline)
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
Pre-test (baseline)
Diabetes health literacy scale
大体时间:3 months after intervnetion
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
3 months after intervnetion
Diabetes health promotion scale
大体时间:Pre-test (baseline)
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
Pre-test (baseline)
Diabetes health promotion scale
大体时间:1 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
1 months after intervnetion
Diabetes health promotion scale
大体时间:3 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
大体时间:3 months after intervnetion
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months.
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
大体时间:Pre-test (baseline)
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months
Pre-test (baseline)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年5月12日

初级完成 (实际的)

2020年10月30日

研究完成 (实际的)

2021年6月30日

研究注册日期

首次提交

2022年3月14日

首先提交符合 QC 标准的

2026年9月4日

首次发布 (实际的)

2026年9月9日

研究记录更新

最后更新发布 (实际的)

2026年9月9日

上次提交的符合 QC 标准的更新

2026年9月4日

最后验证

2021年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅